1. Name of the grant: NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
2. Description of the grant: This grant aims to support the implementation of clinical trials related to musculoskeletal, rheumatologic, and skin diseases funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The cooperative agreement requires the conduct of a clinical trial as part of the research project.
3. Research project title: The title or name of your proposed research project.
4. Project abstract: A concise summary of the proposed research project, including the objectives, methods, and expected outcomes.
5. Investigators: Names and affiliations of the principal investigator(s) and other key personnel involved in the project.
6. Research team: A description of the qualifications and expertise of the research team members, highlighting their relevance to the project.
7. Study site(s): Information about the location(s) where the clinical trial will be conducted, including details about the facilities and resources available.
8. Study population: Description of the target population for the clinical trial, including demographic information and relevant eligibility criteria.
9. Research plan: Detailed information about the study design, methodology, interventions, procedures, and data analysis.
10. Timeline: A proposed timeline outlining the project's various stages, from recruitment and enrollment to data collection and publication of results.
11. Budget: A detailed budget plan for the grant funds, including anticipated expenses for personnel, equipment, supplies, travel, and other project-related costs.
12. Data management: Description of the plans for data collection, storage, and analysis, including any data management systems or software to be utilized.
13. Regulatory approvals: Documentation of any necessary ethical approvals, institutional review board (IRB) certifications, and compliance with relevant regulatory requirements.
14. Dissemination plan: Description of how the trial results will be disseminated, including publication in scientific journals, presentations at conferences, and plans for community/public outreach.
15. Potential impact: Explanation of the potential impact and significance of the proposed research project, including its relevance to the field and potential benefits for patients or healthcare practices.
16. Collaborations: Details of any existing collaborations or partnerships with other institutions or organizations relevant to the research project.
17. Letters of support: Letters of support or collaboration from any key individuals or organizations participating in or contributing to the project.
18. Previous experience: Description of any previous experience or publications relevant to the proposed research project, demonstrating the
